We only have this paper's title and publication details.
Read it at the sourceHypothesis-generating for PT plus valsartan-amlodipine in smokers with cardiopulmonary disease; larger trials needed before clinical adoption.
No takes yet. Share an insight, caveat, or question.
Бубнова et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: